Jupiter Life Line Hospitals Limited — Investor Meet, 05-02-2026: Analysts/Institutional Investor Meet/Con. Call Updates

Jupiter Life Line Hospitals saw Q3 FY26 revenue grow 9.8% YoY to INR 365.3 Cr and EBITDA up 9.2% to INR 83.4 Cr (22.8% margin). PAT fell 18.7% to INR 42.5 Cr, impacted by a one-time Labor Code provision. For 9M FY26, revenue increased 15.1% to INR 1,111.9 Cr, with EBITDA up 15.2% to INR 254 Cr (22.8% margin).

The new 500-bed Dombivli hospital is ready for launch, with 200 beds commencing operations. This will lead to higher depreciation and an EBITDA drag for ~2 years as it ramps up, targeting breakeven by year 2. Management highlights strong demand for quality healthcare in Western India, driving long-term expansion plans with a focus on greenfield projects and exploring a seventh hospital. Sentiment is confident on continued growth.